Recommendations for the use of tolvaptan in autosomal dominant polycystic kidney disease: a position statement on behalf of the ERA-EDTA Working Groups on Inherited Kidney Disorder...

by Ron T. Gansevoort, Mustafa Arici, Thomas Benzing
Published 2016-08-01

Author’s Reply to Correspondence: “Effect of Tolvaptan Treatment on Acid−Base Homeostasis in ADPKD Patients”

by Judith E. Heida, Ron T. Gansevoort, Esther Meijer
Published 2021-06-01

Lower HDL-C and apolipoprotein A-I are related to higher glomerular filtration rate in subjects without kidney disease[S]

by Jan A. Krikken, Ron T. Gansevoort, Robin P.F. Dullaart
Published 2010-07-01

Case report: a thiazide diuretic to treat polyuria induced by tolvaptan

by Bart J. Kramers, Maatje D. A. van Gastel, Esther Meijer, Ron T. Gansevoort
Published 2018-07-01

Reference data for the Ruff Figural Fluency Test stratified by age and educational level.

by Gerbrand J Izaks, Hanneke Joosten, Janneke Koerts, Ron T Gansevoort, Joris P Slaets
Published 2011-01-01

Indomethacin reduces glomerular and tubular damage markers but not renal inflammation in chronic kidney disease patients: a post-hoc analysis.

by Martin H de Borst, Ferdau L Nauta, Liffert Vogt, Gozewijn D Laverman, Ron T Gansevoort, Gerjan Navis
Published 2012-01-01

Predictors of progression in albuminuria in the general population: results from the PREVEND cohort.

by Lieneke Scheven, Nynke Halbesma, Paul E de Jong, Dick de Zeeuw, Stephan J L Bakker, Ron T Gansevoort
Published 2013-01-01

Pharmacological treatment of increased vascular risk and cognitive performance in middle-aged and old persons: six-year observational longitudinal study

by Marlise E. A. van Eersel, Sipke T. Visser, Hanneke Joosten, Ron T. Gansevoort, Joris P. J. Slaets, Gerbrand J. Izaks
Published 2020-06-01

Longitudinal study of performance on the Ruff Figural Fluency Test in persons aged 35 years or older.

by Marlise E A van Eersel, Hanneke Joosten, Janneke Koerts, Ron T Gansevoort, Joris P J Slaets, Gerbrand J Izaks
Published 2015-01-01

Statin use and cognitive function: population-based observational study with long-term follow-up.

by Hanneke Joosten, Sipke T Visser, Marlise E van Eersel, Ron T Gansevoort, Henk J G Bilo, Joris P Slaets, Gerbrand J Izaks
Published 2014-01-01

Separating the effects of 24-hour urinary chloride and sodium excretion on blood pressure and risk of hypertension: Results from PREVEND.

by Joep van der Leeuw, Martin H de Borst, Lyanne M Kieneker, Stephan J L Bakker, Ron T Gansevoort, Maarten B Rookmaaker
Published 2020-01-01

The interaction of age and type 2 diabetes on executive function and memory in persons aged 35 years or older.

by Marlise E A van Eersel, Hanneke Joosten, Ron T Gansevoort, Robin P F Dullaart, Joris P J Slaets, Gerbrand J Izaks
Published 2013-01-01

Low Urinary Creatinine Excretion Is Associated With Self-Reported Frailty in Patients With Advanced Chronic Kidney Disease

by Harmke A. Polinder-Bos, Hakan Nacak, Friedo W. Dekker, Stephan J.L. Bakker, Carlo A.J.M. Gaillard, Ron T. Gansevoort
Published 2017-07-01

Statin use and cognitive function: population-based observational study with long-term follow-up.

by Hanneke Joosten, Sipke T Visser, Marlise E van Eersel, Ron T Gansevoort, Henk J G Bilo, Joris P Slaets, Gerbrand J Izaks
Published 2015-01-01

The association of APOE genotype with cognitive function in persons aged 35 years or older.

by Gerbrand J Izaks, Ron T Gansevoort, Aafke M van der Knaap, Gerjan Navis, Robin P F Dullaart, Joris P J Slaets
Published 2011-01-01

Urinary Calcium Excretion and Risk of Chronic Kidney Disease in the General Population

by Jacob M. Taylor, Lyanne M. Kieneker, Martin H. de Borst, Sipke T. Visser, Ido P. Kema, Stephan J.L. Bakker, Ron T. Gansevoort
Published 2017-05-01

Trajectories of Metabolic Risk Factors and Biochemical Markers prior to the Onset of Cardiovascular Disease - The Doetinchem Cohort Study.

by Gerben Hulsegge, Annemieke M W Spijkerman, Yvonne T van der Schouw, Stephan J L Bakker, Ron T Gansevoort, Henriette A Smit, W M Monique Verschuren
Published 2016-01-01

Polycystic Kidney Disease Caused by Bilineal Inheritance of Truncating PKD1 as Well as PKD2 Mutations

by Monique Losekoot, Esther Meijer, E. Christiaan Hagen, Vladimir Belostotsky, Martin de Borst, Aart Tholens, Marion Phylipsen, York Pei, Ron T. Gansevoort, Dorien J.M. Peters
Published 2020-10-01

Plasma potassium, diuretic use and risk of developing chronic kidney disease in a predominantly White population.

by Lyanne M Kieneker, Michele F Eisenga, Michel M Joosten, Rudolf A de Boer, Ron T Gansevoort, Jenny E Kootstra-Ros, Gerjan Navis, Stephan J L Bakker
Published 2017-01-01

The Effect of Renal Function and Hemodialysis Treatment on Plasma Vasopressin and Copeptin Levels

by Esmée M. Ettema, Judith Heida, Niek F. Casteleijn, Lianne Boesten, Ralf Westerhuis, Carlo A.J.M. Gaillard, Ron T. Gansevoort, Casper F.M. Franssen, Debbie Zittema
Published 2017-05-01